Vanicoside E is an antioxidant and antitumor agent. Vanicoside E inhibits L-Tyrosine ( HY-N0473 ) and L-DOPA ( HY-N0304 ) with IC 50 s of 45.23 μM and 189.96 μM, respectively.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Dopamine Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.